Referencing for people who value simplicity, privacy, and speed.Get Citationsy
← Back to Search
Associative Control Of The Immune Response To Cell Surface Antigens.
P. Lake, N. Mitchison
Published 1976 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
The immune response to cell surface antigens is regulated by the activity of helper and suppressor cells, probably of TH and possibly of TCS types. For this to operate, recognition must take place of two or more antigenic determinants, which may be carried on the same (intramoblecular help) or different (intermolecular, intrastructural help) molecules. Regulation of this type has been shown to operate in the response to the murine allo-antigens H-2K, H-2D, Thy-1, and H-minors.
This paper references
THE REQUIREMENT OF MORE THAN ONE ANTIGENIC DETERMINANT FOR IMMUNOGENICITY
K. Rajewsky (1969)
ANTIGENIC COMPETITION BETWEEN POLYPEPTIDYL DETERMINANTS IN NORMAL AND TOLERANT RABBITS
I. Schechter (1968)
Isolation of a murine liver‐specific alloantigen, F antigen, and examination of its immunogenic properties by radioimmunoassay
D. Lane (1976)
Unimpeded Growth of Tumour in Hosts Pre-immunized with Tyrosyl- or Dinitrophenyl-coated Tumour Cells
S. Bauminger (1972)
Antigen-induced inhibition of experimental allergic encephalomyelitis. III. Localization of an inhibitory site distinct from the major encephalitogenic determinant of myelin basic protein.
R. H. Swanborg (1975)
Fine specificity of the H‐2 linked immune response gene for the gallinaceous lysozymes
S. Hill (1975)
Viruses as immunological adjuvants in cancer.
J. Lindemann (1974)
Induction of T-lymphocyte responses to a small molecular weight antigen. III. T-T cell interactions to determinants linked together: suppression vs. enhancement
W. Bullock (1975)
CELL TO CELL INTERACTION IN THE IMMUNE RESPONSE
G. Mitchell (1968)
Allogenic nucleated cells as immunogen and target for plaque-forming cells in mice.
H. Fuji (1971)
T-cell populations with different functions
C. Janeway (1975)
Antibody response induced in vitro to the cell-surface alloantigen Thy–1
P. Lake (1976)
Immunization of Mice against Ehrlich Ascites Tumour using a Hamster/Ehrlich Ascites Tumour Hybrid Cell Line
J. Watkins (1969)
Genetic control of immune responses in vitro. VI. Experimental conditions for the development of helper T-cell activity specific for the terpolymer L-glutamic aicd60-L-alanine30-L-tyrosine10 (GAT) in nonresponder mice
J. Kapp (1975)
T–T interaction in the generation of helper cells in vitro
M. Feldmann (1975)
Genetic regulation of the antibody response to H-2Db alloantigens in mice. I. Differences in activation of helper T cells in C57BL/10 and BALB/c congenic strains.
D. Wernet (1975)
P. Medawar (1975)
Purification of the Thy-1 molecule, a major cell-surface glycoprotein of rat thymocytes.
M. Letarte-Muirhead (1975)
HISTOINCOMPATIBILITIES FOUND BETWEEN CONGENIC STRAINS WHICH DIFFER AT LOCI DETERMINING DIFFERENTIATION ANTIGENS
L. Flaherty (1973)
RECOMBINANT‐INBRED STRAINS AN AID TO FINDING IDENTITY, LINKAGE, AND FUNCTION OF HISTOCOMPATIBILITY AND OTHER GENES
D. W. Bailey (1971)
The involvement of LD- and SD-region differences in MLC and CML: a three-cell experiment.
D. Schendel (1973)
The carrier effect in the secondary response to hapten‐protein conjugates. II. Cellular cooperation
N. Mitchison (1971)
Tolerance, Enhancement and the Regulation of Interactions Between T Cells, B Cells and Macrophages
M. Feldmann (1972)
This paper is referenced by
Autoimmune responses to proliferating cell nuclear antigen multiprotein complexes involved in cell proliferation are strongly associated with their structure and biologic function in patients with systemic lupus erythematosus.
T. Kogure (2002)
Alien Gene Transfection and the Immune Response to Tumors
P. Frost (1992)
Immunization with interleukin‐2‐secreting allogeneic mouse fibroblasts expressing melanoma‐associated antigens prolongs the survival of mice with melanoma
T. Kim (1993)
Identification of CD4+ T Cell Epitopes in C. burnetii Antigens Targeted by Antibody Responses
C. Chen (2011)
Somatic gene therapy for cancer: the utility of transferrinfection in generating 'tumor vaccines'.
K. Zatloukal (1993)
The immunogenetic basis of autoimmunity.
E. Bikoff (1990)
Autoimmunity and the kidney.
D. Oliveira (1989)
A novel reporter strain to follow Cre‐mediated recombination in T and NK cells
O. Wurtz (2002)
Autoantibodies and Autoantigens in Sjögren's Syndrome
K. Nozawa (2011)
Autoimmunity and the pathogenesis of glomerulonephritis
D. Oliveira (2004)
Aktivierung von Monozyten und Lymphozyten durch in vitro Gentransfer und Expression von humanem InterIeukin-2 (hIL-2) in menschlichen Tumorzellen
H. K. Schackert (1993)
Induction in a murine tumor of immunogenic tumor variants by transfection with a foreign gene.
E. Fearon (1988)
Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus
K. Doe (2014)
Adoptive immune therapy in mice bearing poorly immunogenic metastases, using T lymphocytes stimulated in vitro against highly immunogenic mutant sublines
J. Dennis (1984)
Cytotoxic activity toward mouse melanoma following immunization of mice with transfected cells expressing a human melanoma-associated antigen
J. Nowak (2005)
T and B cell responses to neutrophil cytoplasmic antigens in systemic vasculitis.
P. Mathieson (1992)
Afferent and efferent specificity in the induction and elicitation of parental cross-protective immunity by an immunogenic murine tumor variant: associative recognition of a unique tumor-specific antigen on somatic cell hybrids.
S. Legrue (1989)
Immunogenic variants of a murine fibrosarcoma induced by mutagenesis: requirement of viable cells for antigen-specific cross-protection.
S. Legrue (1987)
Monocyte- and Lymphocyte-Mediated Cytotoxicity After Gene Transfer and Expression of Human Interleukin-2 in a Human Glioblastoma Cell Line
G. Schackert (1994)
HIV-1 Antibody Neutralization Breadth Is Associated with Enhanced HIV-Specific CD4+ T Cell Responses
S. Ranasinghe (2015)
New antigens presented on tumor cells can cause immune rejection without influencing the frequency of tumor-specific cytolytic T cells.
P. von Hoegen (1987)
Modification of tumor cells by a low dose of Newcastle Disease Virus.
Paul Von Hoegen (1989)
Antiribonuclease H2 antibodies are an immune biomarker for systemic lupus erythematosus
K. Nozawa (2017)
Suppression of the cytotoxic T cell response to minor alloantigens in vivo Linked recognition by suppressor T cells
N. R. Gascoigne (1984)
Tumor specific antigens induced by mutagens and DNA hypomethylating agents: implications for the immunobiology of neoplasia
R. Kerbel (1986)
How Germinal Centers Evolve Broadly Neutralizing Antibodies: the Breadth of the Follicular Helper T Cell Response
R. D. de Boer (2017)
Immunogenicity of a non-class I MHC expressing murine tumor transfected with the influenza virus hemagglutinin or murine interleukin-2 genes
T. Itaya (2005)
Memory in helper T cells of minor histocompatibility antigens, revealed in vivo by alloimmunizations in combination with Thy‐1 antigen
E. Lightstone (1992)
Aktivierung von Monozyten und Lymphozyten durch in vitro Gentransfer und Expression von humanem Interleukin·2 (hIL.2) in mensch lichen Tumorzellen Activation of Monocytes and Lymphocytes by In Vitro Transfer and Expression of the Human Interleukin·2 Gene (hIL.2) in Human Tumor Cells
Hans Konrad Schackert (2011)
Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?
P. Klasse (2020)
Generation of effector cells from T cell subsets. I. Similar requirements for Lyt T cell subpopulations in the generation of alloreactive and H-2 restricted killer cells.
M. Simon (1979)
Active Specific Immunotherapy with Tumor Cells Expressing a Foreign Gene
H. Schackert (1992)See more